Allergic rhinitis involves an early phase, largely mediated through ma
st cells, and a late phase which involves cellular infiltration and me
diator release. In the early phase, mast cells release mediators as a
result of antigen crosslinking adjacent immunoglobulin E molecules bou
nd to mast cell surfaces. This results in an accumulation of histamine
which gives rise to the characteristic symptoms of rhinitis - sneezin
g, itching, rhinorrhoea and congestion. The late phase of the allergic
response (hours after challenge) involves infiltration of the nasal e
pithelium by eosinophils, basophils, monocytes and T-lymphocytes, whic
h release leukotrienes, kinins, histamine and a host of other mediator
s. The most important part of the late-phase response is probably medi
ated via the production of cytokines (IL-4, IL-5, IL-6, IL-8, GM-CSF a
nd RANTES) by mast cells, TH2 lymphocytes or epithelial cells. The inf
iltration of tissues by cells normally present only in the blood is br
ought about by the production of adhesion molecules, such as VCAM-1 an
d E-selectin, which cause circulating eosinophils, basophils and T-lym
phocytes to adhere to endothelial cells before moving through the endo
thelium into the tissue (diapedesis). Neuronal reflexes also play a ro
le in the allergic response, both by mediating local responses to medi
ators and possibly playing a part in the activation of T-lymphocytes.
The allergic response has also been shown to be less intense in a hot,
humid environment, and more marked in a cold, dry environment, possib
ly due to changes in osmolality of the nasal surface fluid. Similar fa
ctors may play a role in the aetiology of non-allergic rhinitis.